Skip to Content

K U 725 (Hydrochlorothiazide and Moexipril Hydrochloride 25 mg / 15 mg)

Pill with imprint K U 725 is Yellow, Figure eight-shape and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 25 mg / 15 mg. It is supplied by Cobalt Laboratories Inc.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 25 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for K U 725

Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg K U 725
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg K U 725
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg K U 725

Hydrochlorothiazide and Moexipril Hydrochloride

Imprint:
K U 725
Strength:
25 mg / 15 mg
Color:
Yellow
Size:
14.00 mm
Shape:
Figure eight-shape
Availability:
Prescription only
Drug Class:
ACE inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Cobalt Laboratories Inc
Inactive Ingredients:
lactose
magnesium oxide
crospovidone
magnesium stearate
gelatin
hydroxypropyl cellulose
hypromellose
polyethylene glycol 6000
titanium dioxide
ferric oxide red
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide